These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 29682242)
21. The efficacy of furazolidone-based quadruple therapy for eradication of Helicobacter pylori infection in Iranian patients resistant to metronidazole-based quadruple therapy. Ebrahimi-Dariani N; Mirmomen S; Mansour-Ghanaei F; Noormohammadpoor P; Sotodehmanesh R; Haghpanah B; Bahrami H Med Sci Monit; 2003 Aug; 9(8):PI105-8. PubMed ID: 12942042 [TBL] [Abstract][Full Text] [Related]
22. A randomized controlled trial: efficacy and safety of azithromycin, ofloxacin, bismuth, and omeprazole compared with amoxicillin, clarithromycin, bismuth, and omeprazole as second-line therapy in patients with Helicobacter pylori infection. Minakari M; Davarpanah Jazi AH; Shavakhi A; Moghareabed N; Fatahi F Helicobacter; 2010 Apr; 15(2):154-9. PubMed ID: 20402818 [TBL] [Abstract][Full Text] [Related]
23. [Efficacy of triple versus quadruple furazolidone-based eradication regimens for Helicobacter pylori infection]. Lü Z; Xie Y; Lü N; Zhou H; Liu Z; Zhu X; Chen Y; He X; Liu D; Ma J Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(8):572-5. PubMed ID: 24762683 [TBL] [Abstract][Full Text] [Related]
24. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Fallone CA; Chiba N; van Zanten SV; Fischbach L; Gisbert JP; Hunt RH; Jones NL; Render C; Leontiadis GI; Moayyedi P; Marshall JK Gastroenterology; 2016 Jul; 151(1):51-69.e14. PubMed ID: 27102658 [TBL] [Abstract][Full Text] [Related]
25. Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis. Xin Y; Manson J; Govan L; Harbour R; Bennison J; Watson E; Wu O BMC Gastroenterol; 2016 Jul; 16(1):80. PubMed ID: 27460211 [TBL] [Abstract][Full Text] [Related]
26. [The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease]. Veliev AM; Maev IV; Andreev DN; Dicheva DT; Zaborovskii AV; Lobanova EG; Bektemirova LG Ter Arkh; 2019 Aug; 91(8):28-33. PubMed ID: 32598751 [TBL] [Abstract][Full Text] [Related]
27. Update on the first-line treatment for Huang CC; Tsai KW; Tsai TJ; Hsu PI Biomark Res; 2017; 5():23. PubMed ID: 28702193 [TBL] [Abstract][Full Text] [Related]
28. Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials. Lin LC; Hsu TH; Huang KW; Tam KW World J Gastroenterol; 2016 Jun; 22(23):5445-53. PubMed ID: 27340362 [TBL] [Abstract][Full Text] [Related]
30. A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance. Tsay FW; Wu DC; Yu HC; Kao SS; Lin KH; Cheng JS; Wang HM; Chen WC; Sun WC; Tsai KW; Hsu PI Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807915 [TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments. Gisbert JP; Romano M; Gravina AG; Solís-Muñoz P; Bermejo F; Molina-Infante J; Castro-Fernández M; Ortuño J; Lucendo AJ; Herranz M; Modolell I; Del Castillo F; Gómez J; Barrio J; Velayos B; Gómez B; Domínguez JL; Miranda A; Martorano M; Algaba A; Pabón M; Angueira T; Fernández-Salazar L; Federico A; Marín AC; McNicholl AG Aliment Pharmacol Ther; 2015 Apr; 41(8):768-75. PubMed ID: 25703120 [TBL] [Abstract][Full Text] [Related]
32. Nitrofuran-based regimens for the eradication of Helicobacter pylori infection. Buzás GM; Józan J J Gastroenterol Hepatol; 2007 Oct; 22(10):1571-81. PubMed ID: 17845685 [TBL] [Abstract][Full Text] [Related]
33. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia. Gisbert JP; Marcos S; Gisbert JL; Pajares JM Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1303-7. PubMed ID: 11692055 [TBL] [Abstract][Full Text] [Related]
34. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice. Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733 [TBL] [Abstract][Full Text] [Related]
35. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori. Bardhan KD; Morton D; Perry MJ; Sanders DS; Morris P; Rowland A; Thompson M; Mitchell TR; Roberts PM Aliment Pharmacol Ther; 2001 Aug; 15(8):1199-204. PubMed ID: 11472323 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of triple and quadruple Helicobacter pylori eradication therapies in Iranian children: a randomized clinical trial. Bahremand S; Nematollahi LR; Fourutan H; Tirgari F; Nouripour S; Mir E; Aghakhani S Eur J Gastroenterol Hepatol; 2006 May; 18(5):511-4. PubMed ID: 16607146 [TBL] [Abstract][Full Text] [Related]
40. Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran. Mohammadi M; Attaran B; Malekzadeh R; Graham DY Dig Dis Sci; 2017 Aug; 62(8):1890-1896. PubMed ID: 28577244 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]